(Q46981917)
Statements
1 reference
Calcium channel blocker, azelnidipine, reduces lipid hydroperoxides in patients with type 2 diabetes independent of blood pressure (English)
1 reference
Chie Ohmura
1 reference
Hirotaka Watada
1 reference
Tomoaki Shimizu
1 reference
Ken Sakai
1 reference
Hiroshi Uchino
1 reference
Yoshio Fujitani
1 reference
Akio Kanazawa
1 reference
Takahisa Hirose
1 reference
Ryuzo Kawamori
1 reference
25 September 2007
1 reference
1 reference
54
1 reference
5
1 reference
805-811
1 reference